Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-8573

Single-particle
28.1 Å
EMD-8573 Deposition: 23/01/2017
Map released: 08/03/2017
Last modified: 14/02/2018
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-8573

HIV-1 CH505 Transmitted Founder SOSIP.664 Env trimer in Complex with the DH576 Fab from the RV305 Trial

EMD-8573

Single-particle
28.1 Å
EMD-8573 Deposition: 23/01/2017
Map released: 08/03/2017
Last modified: 14/02/2018
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: HIV-1 CH505 Transmitted Founder SOSIP.664 Env trimer in Complex with the DH576 Fab from the RV305 Trial

Deposition Authors: Fera D, Harrison SC
Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
PUBMED: 28235027
DOI: doi:10.1371/journal.ppat.1006182
ISSN: 1553-7374